Search Results 191-200 of 15294 for Humira

1. Namilumab in Subjects with Chronic Pulmonary Sarcoidosis - Mayo Clinic

   Sarcoidosis is a multi-organ autoimmune disease characterized by non-necrotizing granulomas believed to be formed from an exaggerated immune response to ...

2. Predictors of Inflammatory Arthritis in Patients with Hidradenitis Suppurativa and Psoriasis - Mayo Clinic

   The purpose of this study is to identify the incidence and prevalence of inflammatory arthritis in patients with Hidradenitis Suppurativa (HS) and compare them ...

3. A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia - Mayo Clinic

   The purpose of this study is to assess the safety, tolerability, pharmaokinetics, and preliminary effectiveness of mosunetuzumab in participants with relapsed ...

4. Expanded Access Program with Tirasemtiv for the Treatment of Amyotrophic Lateral Sclerosis (ALS) - Mayo Clinic

   About this study. The purpose of this study is to make Tirasemtiv available to a limited group of patients who suffer from ALS, who participated in CY 4031 ...

5. A Study to Evaluate the Safety and Effectiveness of Upadacitinib (ABT-494) in Subjects with Moderately to Severely Active Crohn's Disease - Mayo Clinic

   The objective of this study is to evaluate the efficacy and safety of upadacitinib compared to placebo as induction therapy in subjects with moderately and ...

6. A Study to Evaluate Darvadstrocel in the Treatment of Complex Perianal Fistula in Crohn's Disease Patients - Mayo Clinic

   The purpose of this study is to evaluate the long-term safety of a single dose of darvadstrocel in participants with Crohn's disease (CD) and complex perianal ...

7. Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma - Mayo Clinic

   About this study. RATIONALE: Monoclonal antibodies, such as rituximab, can block cancer growth in different ways. Some find cancer cells and help kill them ...

8. FDA-approved drug to prevent migraine shows promise after Mayo Clinic-involved study

   "It belongs to a family of drugs called calcitonin gene-related peptide, or CGRP, monoclonal antibodies," she explains. "We expect a few more will also be FDA- ...

9. Haloperidol (oral route) - Mayo Clinic

   This medicine is available only with your doctor's prescription. This product is available in the following dosage forms: Tablet; Solution. Back to top ...

10. Tislelizumab-jsgr (intravenous route) - Mayo Clinic

    Tislelizumab-jsgr injection is used to treat esophageal cancer that has spread or cannot be removed by surgery. It is given to patients who have received cancer ...